endpoint launches ConnectionPOINT ™, a collaborative program designed to drive accelerated results and advance medicine through the interconnection of state-of-the-art eClinical technologies

endpoint launches ConnectionPOINT ™, a collaborative program designed to drive accelerated results and advance medicine through the interconnection of state-of-the-art eClinical technologies endpoint launches ConnectionPOINT ™, a collaborative program designed to drive accelerated results and advance medicine through the interconnection of state-of-the-art eClinical technologies

PR Newswire

SANT FRANCESC, April 21, 2021

SANT FRANCESC, April 21, 2021 / PRNewswire / – endpoint Clinical, the world’s leading interactive response technology (IRT®) company, today announced the launch of its collaborative program ConnectionPOINT ™, the first of its kind in the field of eClinical technology. The vision of the program is to achieve a guided convergence of a select network of eClinical providers who are leaders in innovation in their fields and are dedicated to promoting change towards a smarter state-of-the-art interface.

“While this is our official launch of a collaborative program, we have been working together with the best eClinical technology providers to help transform the future of drug development for more than a decade,” he said. stated Ryan Keane, director of endpoint operations. “What we’ve learned from taking on the commitment to build relationships and create technology for so long is that together we can look further to drive the industry and also have the real ability to achieve, and then overcome, those goals. ConnectionPOINT is the result of this success, which gives sponsors the peace of mind that traditionally disparate systems across multiple eClinical providers can not only communicate seamlessly with each other, but also exceed boundaries with speeds and data efficiency that does not exist in the current eClinical ecosystem “.

ConnectionPOINT’s core mission is to foster a sustainable and scalable infrastructure between a network of strong, proven business-supporting alliances and eClinical technology, based on the principles of creating opportunities, driving innovation and harmonizing service delivery. the whole ecosystem.

One of the most attractive applications for these strategic alliances is strengthening the line between technology lines and services that are often considered independent, essential on their own and with common historical intersections, but are now ready to generate new opportunities. disruptive. Here’s what some of the endpoint partners are saying about ConnectionPOINT’s already recognized benefits and achievements through its existing technology that interrelates with endpoint IRT:

“When TSS and endpoint came together to explore what our companies could achieve together in our field, we realized instantly that it was possible to achieve more than the easy successes of legacy contact points like basic monitoring of shipments, ”commented Evan Hahn, vice president for North America for TSS, a leading global provider of temperature monitoring technologies and services. “All the conversations at all levels between endpoint and TSS, from CEOs to Technical SMEs and Business Development, quickly echoed the idea of ​​how far we can go and prepare this part of the ecosystem for the changes that occur in the industry and the great need to share real-time data and functionality around temperature monitoring.It was clear that endpoint and TSS would quickly gather the expected practical bases of an integrated approach.the next step would be to move forward with the next generation of real-time dual-track integration that works beyond the shipping level to the item level, applies to the center inventory as well as to standard shipping needs and is Ready to operate on all frontiers where wireless monitoring technology is opening up this space.This is exactly what we did.This straight line towards a goal does not happen without them organization is very aligned. “

“One of the direct data collection (DDC) options in encapsia®, eSource DDC, represents an important possibility for the industry as an independent alternative, but its main benefit is to bring simplicity to the complex ecosystem of technologies and for this purpose, more than two and a half years ago we enhanced the dynamic encapsulation architecture with the endpoint hyperintegration approach in a joint effort to closely connect systems in a spectrum of experience for centers and study managers alike, ”said Temitope Keyes, CEO of CMED Technology. “Encapsulation and endpoint teams have demonstrated a deep commitment to partnership, customer success, technological innovation and intellectual leadership in the industry, driving our mutual ability to deliver a set of systems. “We offer an intuitive and efficient solution for clinical supplies and clinical operations workflows, always in compliance and using dynamic data in almost real time.”

The spectrum of possibilities can range from a deep interconnection of products to new business models and requires all of the above.

“The tools and systems created by our industry are usually very specific in terms of protocols and are driven by the needs of the sponsor. As a result, plants often end up with countless applications for learning, as well as the associated login credentials to manage and remember, ”noted Rick Malone, McCreadie Group’s Business Development Executive. “We are looking for solutions that offer pharmacological research teams the flexibility to complete the tasks in the workflow they prefer and at the same time meet the specific needs of the sponsor for each protocol. We are happy to work with a partner with ideas. endpoint, which sees the merging of center and sponsor needs through our pioneering integration as a win-win for all parties involved McCreadie Group and endpoint have invested more than a year in developing a solution that makes life easier for the centers, while providing greater speed and data integrity to sponsors. “

“As much as it is a promise to take advantage of the collective experience, strengths and obvious benefits of direct interaction between partners, we recognize that it is also creating a challenge for those who join this collective,” he said. observed Vincent Pulla, senior director of Strategic Endpoint Alliances. “Interact constantly, deepen conversations, break down barriers, consider new business models, and tirelessly ask ‘what’s next?’ and ‘what else can we do?’ it is a considerable commitment. It will not be for everyone, but for those who adopt a mission like ConnectionPOINT, the quality of the results cannot be underestimated. “

Additional information

Visit our website for more information on the endpoint ConnectionPOINT program.

Connect with endpoint on LinkedIn

About endpoint

endpoint is a provider of interactive response technology (IRT®) systems and solutions specializing in the life sciences industry. Over the past decade, its team of client-centered professionals has continuously evolved its technology package to help users achieve good results in their clinical trials. PULSE®, its dynamic IRT solution for randomizing and managing patients, plants and drug supply, and DRIVE, the innovative clinical supply management tool, have been shown to optimize the supply chain and minimize operating costs. way that the timely and accurate administration of the drug to the patient is guaranteed. endpoint is headquartered in San Francisco, California, as well as other offices in the United States, the European Union and Asia. www.endpointclinical.com

contacts:Catherine DitzlerAssociate Director of Clinical Endpoint Marketing 1-415-688-3424Email: [email protected]

Photo: https://mma.prnewswire.com/media/1492520/endpoint_Clinical_Launches_ConnectionPOINT.jpg

FONT endpoint Clinical

.Source